| HOME >> BIOLOGY >> TECHNOLOGY |
Interest income 509 635 1,688 1,731
Other income, net 4 4 188 2
Net income (loss) (7,309) 176 (16,053) 49
Non-cash dividends on Series A
preferred stock (60) (60) (180) (180)
Net income/(loss) applicable to
common stockholders $(7,369) $116 $(16,233) $(131)
Basic net income/(loss) per
share applicable to common
stockholders $(0.72) $0.01 $(1.67) $(0.01)
Diluted net income/(loss) per
share applicable to common
stockholders $(0.72) $0.01 $(1.67) $(0.01)
Weighted average shares used to
compute basic net
income/(loss) per share applicable
to common stockholders 10,182 9,334 9,716 9,316
Weighted average shares used to
compute diluted net income/(loss)
per share applicable to common
stockholders 10,182 11,560 9,716 9,316
The accompanying notes are an integral part of these financial statements.
Condensed Balance Sheet Data
(In thousands)
September 30, December 31,
2007 2006
Cash, cash equivalents and
short-term investments $35,586 $48,669
Total assets $37,801 $50,240
Total stockholders' equity $34,620 $49,064
| SOURCE Ardea Biosciences, Inc. Copyright©2007 PR Newswire. All rights reserved |